PMR Insight: Increase in Gedeon Richter pharmaceutical sales on all CE markets with the exception of the Czech Republic

Justyna Zagórska, Pharmaceutical Market Analyst
Gedeon Richter, the prominent Hungarian manufacturer, saw its total sales increase by 26% in forints and 27% in euro in the first quarter of 2017. The group generated total sales revenues of HUF 112.7bn (€364.6m), including HUF 10.7bn (€34.8m) on the domestic market. International sales were worth €329.8m, a 31% year-on-year increase, and an improvement sales results was recorded in all regions. The Group make a net profit of HUF 20bn (€65m) in the period in question. A slight reduction in sales revenues was observed in Hungary (0.4% in forints), attributed to the sale…

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.